Female Heart – Clinical Research Grants
Supports international collaborative research to advance understanding of sex-related differences in cardiovascular disease, focusing on improving women’s heart health.
Funder: Novo Nordisk Foundation
Due Dates: March 19, 2026 (Phase 1 concept note) | August 12, 2026 (Phase 2 full application)
Funding Amounts: Up to DKK 15 million per grant (3–5 years); total DKK 75 million available in 2026 call.
Summary: Supports international collaborative research to advance understanding of sex-related differences in cardiovascular disease, with a focus on improving women’s heart health.
Key Information: Main applicant must be based in a Nordic country; international collaboration is mandatory.
Description
This program funds large-scale, international clinical research projects focused on sex-related differences in cardiovascular disease, anchored in the Nordic countries. The aim is to enhance clinical understanding and improve outcomes for women by supporting research on early detection, diagnosis, treatment, and the impact of sex-specific risk factors and social determinants. Targeted conditions include, but are not limited to, SCAD, MINOCA, INOCA, Takotsubo cardiomyopathy, and HFpEF. Projects must foster international collaboration and directly address sex-related differences as a core research focus.
